Agios Pharmaceuticals, Inc.
(NASDAQ : AGIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
ARRYArray BioPharma Inc.
0.00%46.428.1%$738.51m
AMGNAmgen Inc.
0.36%176.751.3%$505.40m
CELGCelgene Corporation
0.04%91.801.3%$444.39m
GILDGilead Sciences, Inc.
-1.70%66.910.9%$404.46m
BIIBBiogen Inc.
-0.35%232.811.3%$386.33m
ILMNIllumina, Inc.
0.31%303.233.5%$336.82m
REGNRegeneron Pharmaceuticals, Inc.
-0.09%297.942.6%$277.91m
SRPTSarepta Therapeutics, Inc.
-2.25%153.3814.7%$204.17m
ALXNAlexion Pharmaceuticals, Inc.
0.66%123.852.0%$199.45m
VRTXVertex Pharmaceuticals Incorporated
0.14%176.611.9%$187.74m
EXASExact Sciences Corporation
-0.87%115.1824.1%$139.27m
AAgilent Technologies, Inc.
-0.85%69.951.6%$134.12m
INCYIncyte Corporation
-1.61%80.082.5%$114.23m
BLUEBluebird Bio, Inc.
-1.27%134.0314.3%$97.95m
BMRNBioMarin Pharmaceutical Inc.
-2.13%82.204.3%$87.46m

Company Profile

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.